ButlerPharmacies
YOUR PARTNERS IN HEALTH
Caring For You And About You
Butler Pharmacies is your hometown pharmacy, medical supply and compounding center, we combine high quality products with personalized care. Our knowledgeable staff is happy to help you with any questions you may have. We strive to help you reach your health and wellness goals.
Let MAZIL Help You with Medicare!
Clinton Drug - Clinton
College Hill Pharmacy - Texarkana
Coleman Pharmacy - Ft. Smith
East Gate Pharmacy - Lonsdale
Fountain Lake Family Pharmacy - Hot Springs
Gurdon Pharmacy - Gurdon
Malvern Family Pharmacy - Malvern
West Gate Pharmacy - Hot Springs Village
Butler Pharmacies has 8 great locations to serve you around the state of Arkansas.
We can transfer your prescriptions with ease, refill prescriptions on-line, FREE delivery in most locations, friendly staff, and most of all we are a pharmacy where community matters! Come give us a try today.
"Please read the following in its entirety. Current CDC recommendations at this time regarding the COVID-19
booster vaccine is that it is intended for individuals who meet the following criteria which would have resulted
in them having a reduced immune response to their first two vaccine doses:
- Currently receiving active cancer treatment
- Recipients of organ transplants
- Recipients of stem cell transplants in the past 2 years
- Advanced or untreated HIV infection
- Active treatment with high-dose corticosteroids or medications that suppress the immune system such as biologic medications for rheumatoid arthritis, crohns or ulcerative colitis.
At this time this only applies to about 2% of the population to give them an additional dose of the vaccine since they did not respond adequately to the first two doses. This is a very small number that are in need of this third dose under these recommendations.
Our understanding is that the general population, including all age groups and other conditions that previously qualified people for the vaccine due to being at increased risk for contracting COVID-19, had an appropriate response to the first two doses and will be receiving a new vaccine sometime in the next 2-3 months that will be specific for the delta variant. At this time I anticipate that there will not be any staggered rollout of this vaccine through a phase program like was done with the first vaccine."